140 related articles for article (PubMed ID: 11083108)
1. In vitro percutaneous absorption models.
Bronaugh RL
Ann N Y Acad Sci; 2000; 919():188-91. PubMed ID: 11083108
[TBL] [Abstract][Full Text] [Related]
2. Efficacy and irritancy of enhancers on the in-vitro and in-vivo percutaneous absorption of curcumin.
Fang JY; Hung CF; Chiu HC; Wang JJ; Chan TF
J Pharm Pharmacol; 2003 Aug; 55(8):1175. PubMed ID: 12956910
[No Abstract] [Full Text] [Related]
3. Enhanced absorption through damaged skin: an overview of the in vitro human model.
Gattu S; Maibach HI
Skin Pharmacol Physiol; 2010; 23(4):171-6. PubMed ID: 20185974
[TBL] [Abstract][Full Text] [Related]
4. Modest but increased penetration through damaged skin: an overview of the in vivo human model.
Gattu S; Maibach HI
Skin Pharmacol Physiol; 2011; 24(1):2-9. PubMed ID: 20588085
[TBL] [Abstract][Full Text] [Related]
5. Assessment of delipidization as an enhancing factor in percutaneous penetration.
Menczel E
Curr Probl Dermatol; 1995; 22():189-94. PubMed ID: 7587324
[No Abstract] [Full Text] [Related]
6. Percutaneous penetration and metabolism of 2-butoxyethanol.
Lockley DJ; Howes D; Williams FM
Arch Toxicol; 2004 Nov; 78(11):617-28. PubMed ID: 15455191
[TBL] [Abstract][Full Text] [Related]
7. A comparison of skin delivery of ferulic acid and its derivatives: evaluation of their efficacy and safety.
Zhang LW; Al-Suwayeh SA; Hsieh PW; Fang JY
Int J Pharm; 2010 Oct; 399(1-2):44-51. PubMed ID: 20692328
[TBL] [Abstract][Full Text] [Related]
8. Percutaneous absorption and metabolism of dinitrochlorobenzene in vitro.
Jewell C; Heylings J; Clowes HM; Williams FM
Arch Toxicol; 2000 Sep; 74(7):356-65. PubMed ID: 11043490
[TBL] [Abstract][Full Text] [Related]
9. Prediction of human percutaneous absorption from in vitro and in vivo animal experiments.
Yoshimatsu H; Ishii K; Konno Y; Satsukawa M; Yamashita S
Int J Pharm; 2017 Dec; 534(1-2):348-355. PubMed ID: 29111099
[TBL] [Abstract][Full Text] [Related]
10. Isolated perfused porcine skin flap systems.
Riviere JE
Pharm Biotechnol; 1996; 8():387-407. PubMed ID: 8791821
[No Abstract] [Full Text] [Related]
11. [Percutaneous absorption].
Lafforgue C; Marty JP
Ann Dermatol Venereol; 2007 Mar; 134(3 Pt 2):2S18-23. PubMed ID: 17563709
[No Abstract] [Full Text] [Related]
12. Reconstructed skin equivalents for assessing percutaneous drug absorption from pharmaceutical formulations.
Zghoul N; Fuchs R; Lehr CM; Schaefer UF
ALTEX; 2001; 18(2):103-6. PubMed ID: 11378682
[TBL] [Abstract][Full Text] [Related]
13. Efficacy and irritancy of enhancers on the in-vitro and in-vivo percutaneous absorption of curcumin.
Fang JY; Hung CF; Chiu HC; Wang JJ; Chan TF
J Pharm Pharmacol; 2003 May; 55(5):593-601. PubMed ID: 12831501
[TBL] [Abstract][Full Text] [Related]
14. Measurement of bioavailability: measurement of absorption through skin in vitro.
Hotchkiss SA
Curr Protoc Toxicol; 2001 May; Chapter 5():Unit 5.1.1-14. PubMed ID: 20949434
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of in-vivo animal and in-vitro models for prediction of dermal absorption in man.
Jakasa I; Kezic S
Hum Exp Toxicol; 2008 Apr; 27(4):281-8. PubMed ID: 18684798
[TBL] [Abstract][Full Text] [Related]
16. Percutaneous penetration and metabolism of 2-ethoxyethanol.
Lockley DJ; Howes D; Williams FM
Toxicol Appl Pharmacol; 2002 Apr; 180(2):74-82. PubMed ID: 11969374
[TBL] [Abstract][Full Text] [Related]
17. Can models of percutaneous absorption based on in vitro data in frogs predict in vivo absorption?
Llewelyn VK; Berger L; Glass BD
PLoS One; 2020; 15(7):e0235737. PubMed ID: 32726322
[TBL] [Abstract][Full Text] [Related]
18. Skin absorption and human risk assessment.
Poet TS; McDougal JN
Chem Biol Interact; 2002 Apr; 140(1):19-34. PubMed ID: 12044558
[TBL] [Abstract][Full Text] [Related]
19. In vitro and in vivo percutaneous absorption of catechol.
Jung CT; Wickett RR; Desai PB; Bronaugh RL
Food Chem Toxicol; 2003 Jun; 41(6):885-95. PubMed ID: 12738194
[TBL] [Abstract][Full Text] [Related]
20. Research Techniques Made Simple: Drug Delivery Techniques, Part 2: Commonly Used Techniques to Assess Topical Drug Bioavailability.
Patel P; Schmieder S; Krishnamurthy K
J Invest Dermatol; 2016 May; 136(5):e43-e49. PubMed ID: 27107377
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
